Precise Treatments through Cancer Genomics
Webinar

Precise Treatments through Cancer Genomics

In this webinar, Linda Mileshkin will discuss the future of cancer precision medicine through the lens of omics data.

Share

This webinar will be hosted live and available on-demand

Tuesday, October 28th, 2025
4:00 PM - 5:30 PM ET

Precision medicine enabled by genetic and molecular profiling advances helps scientists and clinicians more easily tailor diagnostics and treatments for a range of conditions. Researchers increasingly gain novel insights into cancer treatment and therapy resistance by employing next-generation sequencing techniques. 

In this webinar brought to you by The Scientist, Linda Mileshkin will discuss how technologies such as whole genome support the future of cancer precision medicine.

Topics to be covered:

  • How whole genome sequencing of cell-free DNA helps elucidate treatment options for cancers of unknown primary
Linda Mileshkin

Linda Mileshkin, MBBS
Professor
Director of Medical Oncology
Peter MacCallum Cancer Center 

Sponsored by

  • Bio-Rad
  • Cellecta logo
  • Sampled

Top Image Credit:

iStock: Jian Fan

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies